Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 73576 - 73600 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	USP32P1	162632	upregulated	Silicon Dioxide analog results in increased expression of USP32P1 mRNA	17p11.2	A24194
Silicon dioxide	Approved	USP44	84101	upregulated	Silicon Dioxide analog results in increased expression of USP44 mRNA	12q21.33	A24195
Silicon dioxide	Approved	USP49	25862	upregulated	Silicon Dioxide analog results in increased expression of USP49 mRNA	6p21.1	A24194
Silicon dioxide	Approved	USP53	54532	downregulated	Silicon Dioxide analog results in decreased expression of USP53 mRNA	4q26	A24195
Silicon dioxide	Approved	UST	10090	upregulated	Silicon Dioxide analog results in increased expression of UST mRNA	6q25.1	A24195
Silicon dioxide	Approved	UTP11	51118	upregulated	Silicon Dioxide analog results in increased expression of UTP11 mRNA	1p34.3	A24195
Silicon dioxide	Approved	UTP3	57050	upregulated	Silicon Dioxide results in increased expression of UTP3 mRNA	4q13.3	A24196
Silicon dioxide	Approved	UTS2	10911	upregulated	Silicon Dioxide analog results in increased expression of UTS2 mRNA	1p36.23	A24194
Silicon dioxide	Approved	VAC14	55697	downregulated	Silicon Dioxide analog results in decreased expression of VAC14 mRNA	16q22.1-q22.2	A24195
Silicon dioxide	Approved	VAMP1	6843	downregulated	Silicon Dioxide analog results in decreased expression of VAMP1 mRNA	12p13.31	A24195
Silicon dioxide	Approved	VAMP5	10791	upregulated	Silicon Dioxide analog results in increased expression of VAMP5 mRNA	2p11.2	A24195
Silicon dioxide	Approved	VAMP8	8673	downregulated	Silicon Dioxide analog results in decreased expression of VAMP8 mRNA	2p11.2	A24195
Silicon dioxide	Approved	VASH2	79805	downregulated	Silicon Dioxide analog results in decreased expression of VASH2 mRNA	1q32.3	A24195
Silicon dioxide	Approved	VASN	114990	downregulated	Silicon Dioxide analog results in decreased expression of VASN mRNA	16p13.3	A24195
Silicon dioxide	Approved	VAT1	10493	upregulated	Silicon Dioxide analog results in increased expression of VAT1 mRNA	17q21.31	A24195
Silicon dioxide	Approved	VAT1L	57687	upregulated	Silicon Dioxide analog results in increased expression of VAT1L mRNA	16q23.1	A24194
Silicon dioxide	Approved	VAV1	7409	upregulated	Silicon Dioxide analog results in increased expression of VAV1 mRNA	19p13.3	A24195
Silicon dioxide	Approved	VAV3	10451	downregulated	Silicon Dioxide analog results in decreased expression of VAV3 mRNA	1p13.3	A24195
Silicon dioxide	Approved	VAV3	10451	downregulated	Silicon Dioxide results in decreased expression of VAV3 mRNA	1p13.3	A24196
Silicon dioxide	Approved	VCAM1	7412	upregulated	Silicon Dioxide analog results in increased expression of VCAM1 mRNA	1p21.2	A24194
Silicon dioxide	Approved	VCAN	1462	downregulated	Silicon Dioxide analog results in decreased expression of VCAN mRNA	5q14.2-q14.3	A24195
Silicon dioxide	Approved	VCAN	1462	upregulated	Silicon Dioxide analog results in increased expression of VCAN mRNA	5q14.2-q14.3	A24194
Silicon dioxide	Approved	VCAN	1462	downregulated	Silicon Dioxide results in decreased expression of VCAN mRNA	5q14.2-q14.3	A24196
Silicon dioxide	Approved	VCP	7415	upregulated	Silicon Dioxide results in increased expression of VCP mRNA	9p13.3	A24196
Silicon dioxide	Approved	VDR	7421	upregulated	Silicon Dioxide analog results in increased expression of VDR mRNA	12q13.11	A24195

Displaying entries 73576 - 73600 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability